(Q42138892)

17 October 2017

https://api.crossref.org/v1/works/http://dx.doi.org/10.7164/antibiotics.45.868

14 December 2019

title

A new macrocyclic lactam antibiotic, BE-14106. I. Taxonomy, isolation, biological activity and structural elucidation (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1500352

2 October 2022

1 reference

9,10-Dihydroxy-7,15-dimethyl-20-(2-hexenyl)azacycloeicosa-3,5,7,11,13,15,17-heptaen-2-one

1 reference

inferred from

reverse claim

(3E,5E,7E,11Z,13E,15E,17E)-20-[(E)-hex-2-enyl]-9,10-dihydroxy-7,15-dimethyl-1-azacycloicosa-3,5,7,11,13,15,17-heptaen-2-one

1 reference

KATSUHISA KOJIRI

1

1 reference

https://api.crossref.org/v1/works/http://dx.doi.org/10.7164/antibiotics.45.868

14 December 2019

SHIGERU NAKAJIMA

2

1 reference

https://api.crossref.org/v1/works/http://dx.doi.org/10.7164/antibiotics.45.868

14 December 2019

HAJIME SUZUKI

3

1 reference

https://api.crossref.org/v1/works/http://dx.doi.org/10.7164/antibiotics.45.868

14 December 2019

HISAO KONDO

4

1 reference

https://api.crossref.org/v1/works/http://dx.doi.org/10.7164/antibiotics.45.868

14 December 2019

HIROYUKI SUDA

5

1 reference

https://api.crossref.org/v1/works/http://dx.doi.org/10.7164/antibiotics.45.868

14 December 2019

K. Kojiri

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1500352

2 October 2022

S. Nakajima

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1500352

2 October 2022

H. Suzuki

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1500352

2 October 2022

H. Kondo

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1500352

2 October 2022

H. Suda

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1500352

2 October 2022

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=1500352

full work available at URL

2 October 2022

publication date

1992

3 references

16 September 2022

16 September 2022

https://www.jstage.jst.go.jp/article/antibiotics1968/45/6/45_6_868/_pdf

1 reference

19 March 2024

https://api.unpaywall.org/v2/10.7164/antibiotics.45.868?email=unpaywall_01@example.com

published in

The Journal of Antibiotics

2 references

17 October 2017

https://api.crossref.org/v1/works/http://dx.doi.org/10.7164/antibiotics.45.868

14 December 2019

volume

45

2 references

17 October 2017

https://api.crossref.org/v1/works/http://dx.doi.org/10.7164/antibiotics.45.868

14 December 2019

issue

6

2 references

17 October 2017

https://api.crossref.org/v1/works/http://dx.doi.org/10.7164/antibiotics.45.868

14 December 2019

page(s)

868-874

2 references

17 October 2017

https://api.crossref.org/v1/works/http://dx.doi.org/10.7164/antibiotics.45.868

14 December 2019

1 reference

19 March 2024

https://api.unpaywall.org/v2/10.7164/antibiotics.45.868?email=unpaywall_01@example.com

access restriction status

open access

1 reference

based on heuristic

inferred from online access status

cites work

Metastasis suppressor genes.

1 reference

12 April 2024

https://opencitations.net/index/api/v1/references/10.7164/ANTIBIOTICS.45.868

A general theory of carcinogenesis

1 reference

12 April 2024

https://opencitations.net/index/api/v1/references/10.7164/ANTIBIOTICS.45.868

A new antitumor antibiotic, stubomycin

2 references

12 April 2024

https://opencitations.net/index/api/v1/references/10.7164/ANTIBIOTICS.45.868

12 April 2024

https://opencitations.net/index/api/v1/citations/10.7164/ANTIBIOTICS.34.259

Antitumor activity of new morpholino anthracyclines

1 reference

12 April 2024

https://opencitations.net/index/api/v1/references/10.7164/ANTIBIOTICS.45.868

Synthetic analogues of fumagillin that inhibit angiogenesis and suppress tumour growth

1 reference

12 April 2024

https://opencitations.net/index/api/v1/references/10.7164/ANTIBIOTICS.45.868

Studies on a new epidermal growth factor-receptor kinase inhibitor, erbstatin, produced by MH435-hF3

2 references

12 April 2024

https://opencitations.net/index/api/v1/references/10.7164/ANTIBIOTICS.45.868

12 April 2024

https://opencitations.net/index/api/v1/citations/10.7164/ANTIBIOTICS.39.170

Mutation and cancer: statistical study of retinoblastoma

1 reference

12 April 2024

https://opencitations.net/index/api/v1/references/10.7164/ANTIBIOTICS.45.868

3'-Hydroxyesorubicin. Synthesis and antitumor activity

1 reference

12 April 2024

https://opencitations.net/index/api/v1/references/10.7164/ANTIBIOTICS.45.868

Identifiers

1 reference

https://api.crossref.org/v1/works/http://dx.doi.org/10.7164/antibiotics.45.868

14 December 2019

1 reference